The publications on this site are part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Skip to Page Content

Attention Strategic Transactions Users:

Coming Spring 2020! A Better Commercial Strategy Solution. Learn More!


Why Use Strategic Transactions?

Strategic Transactions is the most trusted source of life sciences deal intelligence available. For over 20 years executives have trusted and relied on it for world-class analysis on global M&A, financing and alliance deals. Each deal record in Strategic Transactions outlines the structure and terms of the agreement, financial details, relevant company information, SEC contracts where available, and links to related analysis from Informa publications including "The Pink Sheet" and IN VIVO. Learn more.

Who Uses Strategic Transactions?

Strategic Transactions is used by life sciences and medical device companies and tech transfer institutions, as well as the service providers to those groups including venture capital companies, investment banks, consultants, and law firms, amongst others. They rely on the information in Strategic Transactions  to:

  • Confidently and accurately inform deal structuring efforts with relevant, comparable deals
  • Find and profile potential partners and/or acquisition candidates based on the target's stage of development, technologies, and therapeutic area(s) of focus
  • Monitor competition
  • Value their own and their partners' drug candidates
  • See which companies are getting funding and from whom...and to accurately inform many other strategic initiatives.

Click here to register for a free demonstration.